Bio-Techne
TECH
$67.52
Share price
-1.33%
Change (1 day)
-31.07%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Earnings for Bio-Techne (TECH)
Earnings in 2023 (TTM): $0.29 B
According to Bio-Techne's latest financial reports the company's current earnings (TTM) are $0.29 B. In 2022 the company made an earning of $0.29 B an increase over its 2021 earnings that were of $0.26 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bio-Techne from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $0.29 B | 1.26% |
| 2022 | $0.29 B | 12.35% |
| 2021 | $0.26 B | 40.38% |
| 2020 | $0.18 B | 18.72% |
| 2019 | $0.15 B | 8.47% |
| 2018 | $0.14 B | 17.27% |
| 2017 | $0.12 B | -0.93% |
| 2016 | $0.12 B | -13.28% |
| 2015 | $0.14 B | -6.56% |
| 2014 | $0.15 B | -1.46% |
| 2013 | $0.15 B | -2.16% |
| 2012 | $0.16 B | -3.5% |
| 2011 | $0.16 B | 6.2% |
| 2010 | $0.15 B | -0.59% |
| 2009 | $0.15 B | 2.78% |
| 2008 | $0.15 B | 14.95% |
| 2007 | $0.13 B | 15.14% |
| 2006 | $0.11 B | 11.66% |
| 2005 | $0.10 B | 17.05% |
| 2004 | $88.43 M | 18.06% |
| 2003 | $74.9 M | 26.18% |
| 2002 | $59.36 M | 22.74% |
| 2001 | $48.36 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $6.17 B | 1,964.27% | 🇺🇸 USA |
 Becton Dickinson BDX | $1.80 B | 502.79% | 🇺🇸 USA |
 General Electric GE | $10.65 B | 3,463.54% | 🇺🇸 USA |
 Danaher DHR | $7.55 B | 2,427.23% | 🇺🇸 USA |
 Qiagen QGEN | $0.47 B | 57.81% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | -$45.58 M | -115.25% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -$0.54 B | -278.46% | 🇺🇸 USA |